Ravindra Kumar, SVP & Chief Scientific Officer at ACCELERON PHARMA INC (XLRN), sold 4,300 shares at $42.41 ($182K) on 2018-01-02, disclosed to the SEC on 2018-01-04.
Open-market sale of $182k XLRN by SVP & Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| XLRN | SELL | 2017-09-14 | $176K | — | Filing → |
| XLRN | SELL | 2017-08-09 | $463K | — | Filing → |
| XLRN | SELL | 2016-10-11 | $1.8M | — | Filing → |